Investment House LLC trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.0% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 68,946 shares of the financial services provider’s stock after selling 2,138 shares during the quarter. Investment House LLC’s holdings in iShares Biotechnology ETF were worth $9,366,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Glass Jacobson Investment Advisors llc grew its stake in shares of iShares Biotechnology ETF by 150.6% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 122 shares during the period. Values First Advisors Inc. purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at about $43,000. Horizon Bancorp Inc. IN purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $44,000. Tennessee Valley Asset Management Partners purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $44,000. Finally, Column Capital Advisors LLC purchased a new position in iShares Biotechnology ETF in the 3rd quarter worth approximately $49,000. 62.45% of the stock is currently owned by institutional investors.
iShares Biotechnology ETF Stock Up 1.9 %
NASDAQ IBB traded up $2.41 during trading hours on Monday, reaching $128.90. The company’s stock had a trading volume of 789,227 shares, compared to its average volume of 1,782,724. The firm’s 50-day moving average price is $134.27 and its 200-day moving average price is $129.83. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16.
iShares Biotechnology ETF Dividend Announcement
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Further Reading
- Five stocks we like better than iShares Biotechnology ETF
- What Are Growth Stocks and Investing in Them
- The 3 Hottest Insiders Buys This Month
- Where Do I Find 52-Week Highs and Lows?
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- Comparing and Trading High PE Ratio Stocks
- Microsoft Analysis: Trends, Predictions & Investment Insight
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.